Use of Jumping Mechanography as a Method to Assess Musculoskeletal Status in Older Adults
This study has been completed.
Information provided by (Responsible Party):
University of Wisconsin, Madison
First received: January 7, 2008
Last updated: October 1, 2015
Last verified: January 2008
Decline in muscle function may increase risk of hip fracture and decrease quality of life. Different tests are currently used to measure muscle function but they do not work for all individuals. A test called "jumping mechanography," which measures jumping power, may be useful in more people and obtain better information. This study will help us determine whether this test is able to detect differences between muscle function in younger and older adults, as well as whether it is a safe method to use in all ages.
||Observational Model: Cohort
Time Perspective: Cross-Sectional
||Use of Jumping Mechanography as a Method to Assess Musculoskeletal Status in Older Adults: A Pilot Study
Primary Outcome Measures:
- The primary outcome is the instantaneous weight corrected peak power taken from the maximal countermovement jump [ Time Frame: single session ] [ Designated as safety issue: No ]
| Estimated Enrollment:
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||March 2008 (Final data collection date for primary outcome measure)
Men and women 60 years and older
Men and women 20-30 years of age
|Ages Eligible for Study:
||20 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Men and women 60 years and older and men and women 20-30 years of age
- Women and men aged 20 to 30 or ≥ 60 years
- Able and willing to sign informed consent.
- Ability to stand without assistance.
- Acute pain different and/or worse than the individuals chronic baseline pain
- History of recent trauma to musculoskeletal system
- Neuromuscular disease impairing balance to the degree of not being able to stand without assistance.
- History of fragility fracture within the last year
- Patients with a BMD T-score of less than -3.5 at any measured site and a vertebral fracture.
- History of severe end-organ disease, e.g., cardiovascular, hepatic, hematologic, pulmonary, etc., which might limit the ability to complete this study.
- Recent history of malignancy with metastasis to the musculoskeletal system.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00596089
|University of Wisconsin Osteoporosis Clinical and Research Program
|Madison, Wisconsin, United States, 53705 |
University of Wisconsin, Madison
||Neil C Binkley, MD
||University of Wisconsin - Institute on Aging
No publications provided
||University of Wisconsin, Madison
History of Changes
|Other Study ID Numbers:
|Study First Received:
||January 7, 2008
||October 1, 2015
||United States: Institutional Review Board
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on October 08, 2015
Nervous System Diseases
Signs and Symptoms